Equity Overview
Price & Market Data
Price: $2.35
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $20,297,028
Volume: 0
Performance Metrics
1 Week: 8.51%
1 Month: 0.20%
3 Months: -14.38%
6 Months: -20.72%
1 Year: -17.38%
YTD: -20.99%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is in Phase 2 clinical studies for the treatment of solid tumor, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, colon cancer and glioblastoma multiforme, in combination with a range of anti-cancer regimens. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.